Fulgent Genetics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Fulgent Genetics generated cash of $27,003,000, which is less than the previous year. Cash used in financing activities reached the amount of -$47,785,000 last year. Net change in cash is therefore $17,967,000.
Cash Flow
| 2014 | -4.39M | -780K | 4M |
|---|---|---|---|
| 2015 | -969K | -2.20M | 3.5M |
| 2016 | 4.40M | -42.79M | 45.78M |
| 2017 | 1.33M | -2.04M | -770K |
| 2018 | -675K | 950K | 15K |
| 2019 | 5.51M | -29.04M | 28.77M |
| 2020 | 140.62M | -326.43M | 261.25M |
| 2021 | 538.57M | -546.54M | 85.39M |
| 2022 | 253.52M | -261.31M | -77.14M |
| 2023 | 27.00M | 38.89M | -47.78M |
FLGT Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 79.50M | 164.89M | 87.42M | 11.96M | 6.73M | 6.49M | 7.89M | 498K | 172K | 1.34M |
Operating activities | ||||||||||
Net income | -167.82M | 141.92M | 506.23M | 214.31M | -411K | -5.60M | -2.51M | -5.38M | -4.98M | -990K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 31.75M | 32.66M | 11.00M | 2.96M | 2.10M | 2.16M | 1.72M | 1.17M | 575K | 196K |
Stock-based compensation expense | 42.92M | 32.64M | 15.88M | 8.15M | 3.20M | 0 | 2.11M | 4.65M | 8.15M | 0 |
| Deferred income tax benefit | 42.92M | 32.64M | 15.88M | 8.15M | 3.20M | 0 | 2.11M | 4.65M | 8.15M | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 2.38M | 68.63M | 42.3M | -178.48M | -839K | -1.97M | 214K | -2.32M | -1.77M | -416K |
Inventories | 0 | 0 | 0 | 0 | 0 | -36.18M | -30.49M | -23.45M | -2.34M | -331K |
Accounts payable | -6.89M | -25.33M | -12.20M | 22.61M | -329K | 102K | -363K | 1.09M | 132K | 150K |
Cash generated by operating activities | 27.00M | 253.52M | 538.57M | 140.62M | 5.51M | -675K | 1.33M | 4.40M | -969K | -4.39M |
Investing activities | ||||||||||
Purchases Of Investments | -491.91M | -432.98M | -730.49M | -324.35M | -52.07M | -24.18M | -11.65M | -39.01M | 0 | 0 |
Investments In Property Plant And Equipment | -22.20M | -18.77M | -23.84M | -36.51M | -1.31M | -2.83M | -5.35M | -3.78M | -2.1M | -731K |
Acquisitions Net | -399K | -182.67M | -61.86M | -2.59M | 137K | 510K | 2.46M | 10K | 3.57M | 0 |
Cash generated by investing activities | 38.89M | -261.31M | -546.54M | -326.43M | -29.04M | 950K | -2.04M | -42.79M | -2.20M | -780K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 89.56M | 246.19M | 28.75M | 15K | -770K | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.59M | 0 | 0 |
Repurchases of common stock | -27.79M | -76.10M | -4.15M | -62K | -21K | 0 | 0 | -6.58M | 0 | 0 |
Repayments of term debt | -4.99M | -1.06M | -11K | -15.01M | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -47.78M | -77.14M | 85.39M | 261.25M | 28.77M | 15K | -770K | 45.78M | 3.5M | 4M |
Net Change In Cash | 17.96M | -85.38M | 77.46M | 75.46M | 5.22M | 246K | -1.40M | 7.39M | 326K | -1.17M |
Cash at end of period | 97.47M | 79.50M | 164.89M | 87.42M | 11.96M | 6.73M | 6.49M | 7.89M | 498K | 172K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |